On the issue of the use of nootropic drugs in the correction of intellectual development disorders in children


Cite item

Abstract

Abstract. 

Introduction. The problem of using nootropic drugs in the correction of intellectual development disorders in children remains one of the most controversial issues in modern medicine, in particular, due to disputes in the scientific community about the effectiveness of these drugs. This is an important topic that deserves attention and research to improve the quality of life of children with these disorders. The goal of this study is to consider the mechanisms of action and capabilities of some nootropic drugs in the treatment of these disorders in children. Materials and methods. An analysis of literary sources on the mechanisms of action and pharmacological activity of nootropic drugs was carried out. Results. Nootropics improve brain metabolism through various mechanisms of action: increasing oxygen consumption in the brain; increased adenylate kinase activity in the brain; increased synthesis of cytochrome b5; improvement of interhemispheric transmission; increased glucose metabolism in the brain; increasing the plasticity of erythrocytes. In this publication, we would like to pay attention to both the drugs with the longest history of use (Piracetam) and new and possibly promising drugs (Meclofenoxate, Deanol aceglumate and Bacopa Monnieri). Conclusions. Assessing the effectiveness of nootropic drugs from the perspective of evidence-based medicine is difficult due to the high heterogeneity of etiological and pathophysiological factors and significant individual characteristics of intellectual development in children. Research shows that nootropics can improve mental activity, memory, attention, learning ability, and also reduce the oxygen demand of neurons during hypoxia. These drugs also help normalize behavior and correct emotional and behavioral disorders in children. The most common and widely used today is Piracetam. It is a nootropic that promotes intellectual development, improves cognitive function and memory.       

Full Text

.

×

About the authors

Polina Sergeevna Belyaeva

Federal State Budgetary Educational Institution of Higher Education
"St. Petersburg State Pediatric Medical University"
of the Ministry of Health of the Russian Federation

Email: belyaevapolina00@mail.ru
ORCID iD: 0009-0002-3415-596X
Russian Federation, 194100, St. Petersburg, Litovskaya st. 2

Polina Yurevna Klimenko

Federal State Budgetary Educational Institution of Higher Education
"St. Petersburg State Pediatric Medical University"
of the Ministry of Health of the Russian Federation

Email: polinaklmnk@yandex.ru
ORCID iD: 0009-0003-7055-8608
Russian Federation, 194100, St. Petersburg, Litovskaya st. 2

Nadezhda Leonidovna Kosogorova

Federal State Budgetary Educational Institution of Higher Education
"St. Petersburg State Pediatric Medical University"
of the Ministry of Health of the Russian Federation

Email: gennadya.kosogorova@gmail.com
ORCID iD: 0009-0003-9147-5377
Russian Federation, 194100, St. Petersburg, Litovskaya st. 2

Vladimir Vasilievich Rusanovsky

Federal State Budgetary Educational Institution of Higher Education
"St. Petersburg State Pediatric Medical University"
of the Ministry of Health of the Russian Federation

Email: rusvy2058@mail.ru
ORCID iD: 0000-0002-0432-7946
SPIN-code: 7010-4530

Doctor of Medical Sciences, Professor of the Department of Pharmacology with a course of Clinical Pharmacology and Pharmacoeconomics

Russian Federation, 194100, St. Petersburg, Litovskaya st. 2

Alexander Anatolyevich Akimov

Federal State Budgetary Educational Institution of Higher Education
"St. Petersburg State Pediatric Medical University"
of the Ministry of Health of the Russian Federation

Author for correspondence.
Email: akialean@mail.ru
ORCID iD: 0009-0005-1971-5369

Candidate of Medical Sciences, Associate Professor of the Department of Pharmacology with a course of Clinical Pharmacology and Pharmacoeconomics

Russian Federation, 194100, St. Petersburg, Litovskaya st. 2

References

  1. Фардиева Р. М., Залялютдинова Л. Н. ПРИМЕНЕНИЕ НООТРОПОВ ПРИ ИНТЕЛЛЕКТУАЛЬНОЙ НЕДОСТАТОЧНОСТИ У ДЕТЕЙ // Современные проблемы науки и образования. – 2013. – № 2.
  2. Malík, M.; Tlustoš, P. Nootropics as Cognitive Enhancers: Types, Dosage and Side Effects of Smart Drugs. Nutrients 2022, 14, 3367. https://doi.org/10.3390/nu14163367.
  3. Kean JD, Kaufman J, Lomas J, Goh A, White D, Simpson D, Scholey A, Singh H, Sarris J, Zangara A, and Stough C. A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831). Nutrients 7: 9931-9945, 2015.
  4. Dr. Cornelui. Giurgea- The father of Nootropics 15.02.2018.
  5. Ганцгорн Е. В., Макляков Ю. С., Хлопонин Д. П., Матухно А. Е., Куделина О. М., Каркищенко Н. Н. Церебропротекторные эффекты пирацетама и его комбинации с мелаксеном при глобальной ишемии головного мозга у крыс // Биомедицина. 2012. №1.

Supplementary files

There are no supplementary files to display.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies